Clinical investigation of medicinal products for treatment of amyotrophic lateral sclerosis (ALS)

Author：  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.11, Iss.2, 2001-04, pp. : 187-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical investigation of medicinal products in the treatment of epileptic disorders

By  

European Neuropsychopharmacology, Vol. 11, Iss. 3, 2001-06 ,pp. : 253-259

Elsevier

Access to resources Recommend Favorite

The clinical investigation of medicinal products in the treatment of schizophrenia

By  

European Neuropsychopharmacology, Vol. 8, Iss. 3, 1998-08 ,pp. : 247-252

Elsevier

Access to resources Recommend Favorite

Clinical Investigation of Medicinal Products for the Treatment of Migraine

By Kilminster S.  

International Journal of Pharmaceutical Medicine, Vol. 17, Iss. 3-4, 2003-01 ,pp. : 113-115

Adis International

Access to resources Recommend Favorite

Effectiveness of the Treatment with Botulinum Toxin Type A (BTX-A) in the Management of the Spasticity in Patients with Amyotrophic Lateral Sclerosis (ALS)

By  

Clinical Immunology, Endocrine & Metabolic Drugs, Vol. 3, Iss. 1, 2016-06 ,pp. : 73-77

Bentham Science Publishers

Access to resources Recommend Favorite

Current clinical trials in amyotrophic lateral sclerosis

By Bhatt Jaydeep M   Gordon Paul H  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 8, 2007-08 ,pp. : 1197-1207

Informa Healthcare

Access to resources Recommend Favorite